The popularity of GLP-1R drugs has catapulted the treatment landscape of obesity into the spotlight. Reformation for the ...

There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...

Compared with patients without obesity at the time of initial cancer diagnosis, those with obesity had lower rates of 5-year ...

A population-based study indicates that among children with cancer, those with obesity at the time of diagnosis may face an ...

A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like ...

Researchers are exploring whether microorganisms found in cow’s milk and soil can help prevent weight gain typically caused ...

Obesity is an important health issue for patients with chronic kidney disease, speeding its progression, contributing to ...

Learn how your BMI can help identify if your obesity poses serious health risks and what steps to take for better outcomes.

Obesity at cancer diagnosis is associated with inferior survival among children aged 2 to 18 years, according to a stu ...

The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...

In previous First Word columns, I discussed the effects of SGLT2 inhibitors on the kidney to prevent progression of chronic ...